ERBB2 and neoplasm: Depending on the clinical tumour subtype, the triple‐negative and HER2‐positive breast cancer presented relatively higher PLAC8 expression, compared to the luminal‐type, normal‐like and unclassified type of breast cancer (P < .00001) (Figure 1A).